Assessment and treatment plan*
| Assessing risk of diabetes complications |
| • ASCVD and heart failure history |
| • ASCVD risk factors and 10-year ASCVD risk assessment |
| • Staging of chronic kidney disease (see Table 11.1) |
| • Hypoglycemia risk (see Table 4.3) |
| • Assessment for retinopathy |
| • Assessment for neuropathy |
| Goal setting |
| • Set A1C/blood glucose/time in range target |
| • If hypertension is present, establish blood pressure target |
| • Diabetes self-management goals |
| Therapeutic treatment plans |
| • Lifestyle management |
| • Pharmacologic therapy: glucose lowering |
| • Pharmacologic therapy: cardiovascular and renal disease risk factors |
| • Use of glucose monitoring and insulin delivery devices |
| • Referral to diabetes education and medical specialists (as needed) |
| Assessing risk of diabetes complications |
| • ASCVD and heart failure history |
| • ASCVD risk factors and 10-year ASCVD risk assessment |
| • Staging of chronic kidney disease (see Table 11.1) |
| • Hypoglycemia risk (see Table 4.3) |
| • Assessment for retinopathy |
| • Assessment for neuropathy |
| Goal setting |
| • Set A1C/blood glucose/time in range target |
| • If hypertension is present, establish blood pressure target |
| • Diabetes self-management goals |
| Therapeutic treatment plans |
| • Lifestyle management |
| • Pharmacologic therapy: glucose lowering |
| • Pharmacologic therapy: cardiovascular and renal disease risk factors |
| • Use of glucose monitoring and insulin delivery devices |
| • Referral to diabetes education and medical specialists (as needed) |
ASCVD, atherosclerotic cardiovascular disease.
Assessment and treatment planning are essential components of initial and all follow-up visits.